PelGar International Revenue and Competitors
Estimated Revenue & Valuation
- PelGar International's estimated annual revenue is currently $3.5M per year.
- PelGar International's estimated revenue per employee is $56,452
Employee Data
- PelGar International has 62 Employees.
- PelGar International grew their employee count by 0% last year.
PelGar International Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $15M | 150 | -6% | N/A | N/A |
#2 | $15M | 110 | -17% | N/A | N/A |
#3 | $15M | 179 | 11% | N/A | N/A |
#4 | $75M | 817 | 12% | N/A | N/A |
#5 | N/A | 160 | 2% | N/A | N/A |
#6 | $750M | 269 | N/A | N/A | N/A |
#7 | $15M | 133 | -20% | N/A | N/A |
#8 | $15M | 201 | 12% | N/A | N/A |
#9 | $3.5M | 62 | -6% | N/A | N/A |
#10 | $15M | 136 | 11% | N/A | N/A |
What Is PelGar International?
PelGar International Ltd. is a leading manufacturer and distributor of rodenticides and insecticides to the global public health (non-crop) market. PelGar specialises in the formulation of rodenticides based on the actives difenacoum, bromadiolone and brodifacoum and insecticides based on synthetic pyrethroids combined with synergists and insect growth regulators.
keywords:N/AN/A
Total Funding
62
Number of Employees
$3.5M
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
PelGar International News
Liphatech Neogen Corporation, Pelgar International, ... It shows the global market scenario for the forecast period 2022-2029.
... Bayer AG, Ecolab Inc., Neogen Corporation, PelGar International, Rentokil Initial Plc, Rollins Inc., Senestech Corporation, Syngenta AG.
... Going to BASF SE, Kalyani Industries Limited, PelGar International ... The global anticoagulant rodenticides market size was US$ 612.9...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | N/A | 67 | 40% | N/A |
#2 | $8.8M | 88 | -7% | N/A |
#3 | $7.5M | 103 | 5% | N/A |
#4 | $35.6M | 108 | 6% | N/A |
#5 | $3.5M | 113 | -1% | N/A |